(Q46904082)

26 December 2017

title

Early cardiac outcomes following contemporary treatment for childhood acute myeloid leukemia: a North American perspective (English)

1 reference

26 December 2017

childhood acute myeloid leukemia

1 reference

acute myeloid leukemia

1 reference

based on heuristic

inferred from title

1 reference

5

James Feusner

0 references

author name string

Etan Orgel

1

1 reference

26 December 2017

Laura Zung

2

1 reference

26 December 2017

Lingyun Ji

3

1 reference

26 December 2017

Jerry Finklestein

4

1 reference

26 December 2017

David R Freyer

6

1 reference

26 December 2017

publication date

25 February 2013

1 reference

26 December 2017

published in

Pediatric Blood & Cancer

1 reference

26 December 2017

volume

60

1 reference

26 December 2017

issue

9

1 reference

26 December 2017

page(s)

1528-1533

1 reference

26 December 2017

Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.

cites work

1 reference

Outcomes for children and adolescents with cancer: challenges for the twenty-first century

21 January 2018

1 reference

Dose escalation studies of cytarabine, daunorubicin, and etoposide with and without multidrug resistance modulation with PSC-833 in untreated adults with acute myeloid leukemia younger than 60 years: final induction results of Cancer and Leukemia Gr

21 January 2018

1 reference

Anthracycline dose intensification in acute myeloid leukemia

21 January 2018

1 reference

Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort

21 January 2018

1 reference

Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer.

21 January 2018

1 reference

Anthracycline cardiotoxicity in long-term survivors of childhood cancer

21 January 2018

1 reference

Pathophysiology of anthracycline- and radiation-associated cardiomyopathies: implications for screening and prevention

21 January 2018

1 reference

Pathogenesis of cardiotoxicity induced by anthracyclines

21 January 2018

1 reference

Anthracycline-induced clinical heart failure in a cohort of 607 children: long-term follow-up study.

21 January 2018

1 reference

Cardiac dysfunction in severe sepsis and septic shock

21 January 2018

1 reference

Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy.

21 January 2018

1 reference

B-type natriuretic peptide as a marker for cardiac dysfunction in anthracycline-treated children

21 January 2018

1 reference

The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia

21 January 2018

1 reference

Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes

21 January 2018

1 reference

Anthracycline cardiotoxicity: from bench to bedside

21 January 2018

1 reference

Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol

21 January 2018

1 reference

Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy.

21 January 2018

1 reference

Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging

21 January 2018

1 reference

Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab

21 January 2018

1 reference

Amsacrine-associated cardiotoxicity: an analysis of 82 cases

21 January 2018

1 reference

Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience

21 January 2018

1 reference

Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.

21 January 2018

1 reference

Mortality in overweight and underweight children with acute myeloid leukemia

21 January 2018

1 reference

Absence of secondary malignant neoplasms in children with high-risk acute lymphoblastic leukemia treated with dexrazoxane

21 January 2018

1 reference

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

21 January 2018

1 reference

Cardiac profiles of liposomal anthracyclines: greater cardiac safety versus conventional doxorubicin?

21 January 2018

1 reference

The use of liposomal daunorubicin (DaunoXome) in acute myeloid leukemia

21 January 2018

1 reference

Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/PBC.24498

1 reference

26 December 2017

1 reference

26 December 2017